EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer's Disease

被引:12
|
作者
Yeung, Jason H. Y. [1 ]
Palpagama, Thulani H. [1 ]
Wood, Oliver W. G. [1 ]
Turner, Clinton [2 ]
Waldvogel, Henry J. [1 ]
Faull, Richard L. M. [1 ]
Kwakowsky, Andrea [1 ]
机构
[1] Univ Auckland, Dept Anat & Med Imaging, Ctr Brain Res, Fac Med & Hlth Sci, Auckland, New Zealand
[2] Auckland City Hosp, Dept Anat Pathol, LabPlus, Auckland, New Zealand
关键词
glutamate transporter; EAAT2; hippocampus; subiculum; entorhinal cortex; superior temporal gyrus; Alzheimer's disease;
D O I
10.3389/fncel.2021.702824
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is a neuropathological disorder characterized by the presence and accumulation of amyloid-beta plaques and neurofibrillary tangles. Glutamate dysregulation and the concept of glutamatergic excitotoxicity have been frequently described in the pathogenesis of a variety of neurodegenerative disorders and are postulated to play a major role in the progression of AD. In particular, alterations in homeostatic mechanisms, such as glutamate uptake, have been implicated in AD. An association with excitatory amino acid transporter 2 (EAAT2), the main glutamate uptake transporter, dysfunction has also been described. Several animal and few human studies examined EAAT2 expression in multiple brain regions in AD but studies of the hippocampus, the most severely affected brain region, are scarce. Therefore, this study aims to assess alterations in the expression of EAAT2 qualitatively and quantitatively through DAB immunohistochemistry (IHC) and immunofluorescence within the hippocampus, subiculum, entorhinal cortex, and superior temporal gyrus (STG) regions, between human AD and control cases. Although no significant EAAT2 density changes were observed between control and AD cases, there appeared to be increased transporter expression most likely localized to fine astrocytic branches in the neuropil as seen on both DAB IHC and immunofluorescence. Therefore, individual astrocytes are not outlined by EAAT2 staining and are not easily recognizable in the CA1-3 and dentate gyrus regions of AD cases, but the altered expression patterns observed between AD and control hippocampal cases could indicate alterations in glutamate recycling and potentially disturbed glutamatergic homeostasis. In conclusion, no significant EAAT2 density changes were found between control and AD cases, but the observed spatial differences in transporter expression and their functional significance will have to be further explored.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease
    Du, AT
    Schuff, N
    Amend, D
    Laakso, MP
    Hsu, YY
    Jagust, WJ
    Yaffe, K
    Kramer, JH
    Reed, B
    Norman, D
    Chui, HC
    Weiner, MW
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 71 (04): : 441 - 447
  • [32] Glia Maturation Factor Expression in Entorhinal Cortex of Alzheimer’s Disease Brain
    Ramasamy Thangavel
    Duraisamy Kempuraj
    Deirdre Stolmeier
    Poojya Anantharam
    Mohammad Khan
    Asgar Zaheer
    Neurochemical Research, 2013, 38 : 1777 - 1784
  • [33] Glia Maturation Factor Expression in Entorhinal Cortex of Alzheimer's Disease Brain
    Thangavel, Ramasamy
    Kempuraj, Duraisamy
    Stolmeier, Deirdre
    Anantharam, Poojya
    Khan, Mohammad
    Zaheer, Asgar
    NEUROCHEMICAL RESEARCH, 2013, 38 (09) : 1777 - 1784
  • [34] A quantitative regional expression profile of EAAT2 known and novel splice variants reopens the question of aberrant EAAT2 splicing in disease
    Lauriat, Tara L.
    Richler, Esther
    McInnes, L. Alison
    NEUROCHEMISTRY INTERNATIONAL, 2007, 50 (01) : 271 - 280
  • [35] MRI of entorhinal cortex in mild Alzheimer's disease
    Bobinski, M
    de Leon, MJ
    Convit, A
    De Santi, S
    Wegiel, B
    Tarshish, CY
    Saint Louis, LA
    Wisniewski, HM
    LANCET, 1999, 353 (9146): : 38 - 40
  • [36] Quantitative estimations of the entorhinal cortex in Alzheimer's disease
    Artacho-Perula, Emilio
    Insausti, Ricardo
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2007, 29 (01): : 1 - 16
  • [37] Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease
    Takahashi, Kou
    Kong, Qiongman
    Lin, Yuchen
    Stouffer, Nathan
    Schulte, Delanie A.
    Lai, Liching
    Liu, Qibing
    Chang, Ling-Chu
    Dominguez, Sky
    Xing, Xuechao
    Cuny, Gregory D.
    Hodgetts, Kevin J.
    Glicksman, Marcie A.
    Lin, Chien-Liang Glenn
    JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 212 (03): : 319 - 332
  • [38] Loss of astrocytic glutamate transporters EAAT1 and EAAT2 in frontal cortex in Wernicke's encephalopathy
    Hazell, AS
    Danbolt, NC
    Sheedy, D
    JOURNAL OF NEUROCHEMISTRY, 2003, 87 : 61 - 61
  • [39] Comparative MRI volume analyses of hippocampus and entorhinal cortex in mild cognitive impairment and Alzheimer's disease
    Pennanen, C
    Kivipelto, M
    Tuomainen, S
    Hallikainen, M
    Vanhanen, M
    Laakso, M
    Hartikainen, P
    Hanninen, T
    Nissinen, A
    Helkala, EL
    Vainio, P
    Partanen, K
    Soininen, H
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S467 - S467
  • [40] Alternative splicing of glutamate transporter EAAT2 RNA in neocortex and hippocampus of temporal lobe epilepsy patients
    Hoogland, G
    van Oort, RJ
    Proper, EA
    Jansen, GH
    van Rijen, PC
    van Veelen, CW
    van Nieuwenhuizen, O
    Troost, D
    de Graan, PNE
    EPILEPSY RESEARCH, 2004, 59 (2-3) : 75 - 82